← Back to Clinical Trials
Recruiting NCT07096765

NCT07096765 Effect of Injection Duration of Fascial Plane Blocks on Block Success

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07096765
Status Recruiting
Phase —
Sponsor Bursa Yuksek Ihtisas Training and Research Hospital
Condition Nerve Block
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2026-11-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Group OGroup TGroup C

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-08-01 with a primary completion date of 2026-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective observational study aims to evaluate the impact of injection duration during fascial plane blocks on block success and analgesic efficacy in patients undergoing laparoscopic cholecystectomy. The hypothesis is that shorter injection durations increase injection pressure, potentially limiting local anesthetic spread, while longer durations facilitate broader anesthetic distribution.

Eligibility Criteria

Inclusion Criteria: * Laparoscopic cholecystectomy surgery * Patients with ASA (American Society of Anaesthetists) scores I and III will be included. Exclusion Criteria: * Uncontrolled Arterial Hypertension * Uncontrolled Diabetes Mellitus, * Mental retardation * Antidepressant use * Metabolic disorders * Bleeding diathesis * Patients with a body mass index above 30

Contact & Investigator

Central Contact

Korgün Ökmen, PhD.

✉ korgunokmen@gmail.com

📞 05057081021

Frequently Asked Questions

Who can join the NCT07096765 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Nerve Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07096765 currently recruiting?

Yes, NCT07096765 is actively recruiting participants. Contact the research team at korgunokmen@gmail.com for enrollment information.

Where is the NCT07096765 trial being conducted?

This trial is being conducted at Bursa, Turkey (Türkiye).

Who is sponsoring the NCT07096765 clinical trial?

NCT07096765 is sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology